|
The Heinrich Pette Institute - Leibniz Institute for Experimental Virology (HPI) was founded in 1948 by Heinrich Pette, a German neurologist. It began as a research facility to create polio vaccine. It is now a private foundation and involved with basic research in virology and the immune responses of organisms. The institute is a non-profit public beneficiary organisation and an independent member of the Leibniz Association and is located at the University of Hamburg. ==Research== The aim of the research at the Heinrich Pette Institute is to develop new approaches for improved diagnostic techniques and therapies for viral diseases and virus-associated tumor diseases. Scholars of the HPI explore a wide range of viruses, such as hepatitis viruses (HPV, HCV), herpes viruses (HSV1, HSV2, EBV, KSHV), leukemia viruses (HTLV -1, MLV), human immunodeficiency virus (HIV) and DNA tumor viruses (adenoviruses, SV 40). The drive towards practical applications of the results in diagnosis and treatment is reflected in numerous collaborations with clinical institutions and industry. The HPI is divided into four research departments and three independent research groups. The research spectrum is broadened by two independent groups of young newcomers, who are devoted to current issues of virology. The topics of the current working groups are: • Molecular virology • General virology • Cell biology and virology • Tumor virology • Electron microscopy • Somatic stem cell genetics • Molecular pathology • Cellular virus defence 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Heinrich Pette Institute」の詳細全文を読む スポンサード リンク
|